Stock data

葡萄王 (1707)

葡萄王 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$726.31M, down 7.9% from a year earlier. EPS over the last four quarters totals NT$7.75.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 葡萄王 in Insightr